Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Nexteligent Holdings, Inc. (NXGT)
Avon, CT, US
Nexteligent Holdings, Inc. operates as a key aggregator of healthcare professional services and technology enterprises, providing essential offerings in areas such as telemedicine, expert consulting, and financial administration. Its Telemedicine Solutions arm is dedicated to developing and managing virtual healthcare and technological initiatives. These programs are strategically designed to curb expenses, enhance operational efficiency, and elevate the quality of patient interactions within healthcare institutions. This includes facilities serving the eldercare sector, as well as municipal bodies and various not-for-profit organizations. Furthermore, the company's Financial Services segment offers comprehensive, end-to-end revenue cycle management and specializes in recovering denied claims. This support is extended to a diverse clientele including hospital systems, physician groups, clinics, and long-term care providers. The Financial Services division also furnishes complete, ready-to-deploy solutions for preventative care, encompassing services like chronic condition management, annual wellness visits, transitional care management, behavioral health support, and remote patient telemonitoring. Nexteligent Holdings, Inc.'s primary corporate office is situated in Avon, Connecticut.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +23.81% | +11.43% | -10.96% | +12.39% | -40.00% | -29.73% | -75.63% | -98.87% | -100.00% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Care Facilities: +10.2%+19.1% ★ Q1'26: -46.5% (vs Q1'25)
-
EPS growth Medical - Care Facilities: +19.2%+135.0% ★ Q1'26: +200.0% (vs Q1'25)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%-20.0% Q1'26: -15.7% (vs Q1'25)
-
EBIT margin Medical - Care Facilities: +11.3%+0.5% Q1'26: -15.4% (vs Q1'25)
-
ROIC Medical - Care Facilities: +6.8%— Q1'26: +3.2% (vs Q1'25)
-
Share dilution Medical - Care Facilities: +0.0%+2.5% Q1'26: +3.6% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×1,463.83× Q1'26: -72.79× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-19 | C- | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | C- | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | D+ | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | D+ | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | D+ | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Paul Cristiano | Chief Executive Officer & Vice Chairman | — | — |
| Raymond Pomante | President & Chief Operating Officer | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for NXGT
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
